Delivery Order SPE2DB22D3301-SPE2DB26FX3WU
Award Date 10/27/25
Potential Completion Date 11/18/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,633.80 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) with a firm fixed price structure and an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract represents a single delivery order executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CABENUVA is an injectable antiretroviral...
- The Defense Logistics Agency awarded a delivery order valued at $7,633.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 ml units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CABENUVA is an injectable HIV treatment medication, reflecting the company's role in...
- The Defense Logistics Agency awarded a $22,901.40 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6ML) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract is non-set-aside and represents a competitive award to support federal pharmaceutical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,078.08 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 mg-600 mg suspension in 4 mL formulation, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the breadth of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,169 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) on August 22, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, representing the company's...
- The Defense Logistics Agency awarded a $38,169.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), with an ultimate completion date of May 15, 2025. This non-set-aside competitive award represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- This delivery order, valued at $22,901.40, was awarded on August 7, 2025, by the Medical Supply Chain division of the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL). The award represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of CABENUVA ER (cabotegravir/rilpivirine) 600 mg-900 mg suspension in 6 mL vials, valued at $38,169.00. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract has an ultimate completion date of October 3, 2025, and will be performed at the awardee's location in...
- The Defense Logistics Agency Medical Supply Chain awarded a $38,169 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for CABENUVA ER 600 MG-900 MG Suspension in 6 mL units. This firm fixed-price delivery order, which represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreements, is scheduled for completion by September 18, 2025, with performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL quantities, valued at $3,816.90. This is a firm fixed price delivery order with an ultimate completion date of July 14, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...